首页> 外国专利> Human Unshared Protein-2 Monobasic Polymorphism Marker for Predicting Risk of Atherosclerosis and Vascular Disease

Human Unshared Protein-2 Monobasic Polymorphism Marker for Predicting Risk of Atherosclerosis and Vascular Disease

机译:人类非共享的Protein-2一元多态性标记物,用于预测动脉粥样硬化和血管疾病的风险

摘要

UCP-2(uncoupling protein-2) SNP(single nucleotide polymorphism) makers for the prediction of susceptibility to coronary heart disease and atherosclerosis are provided to analyze correlation between the UCP-2 SNP and obesity, especially indexes of blood cholesterol and atherosclerosis. The UCP-2 SNP makers for the prediction of susceptibility to coronary heart disease and atherosclerosis are -1957GA SNP marker in which a -1957th base from the transcription-starting point of the UCP-2 gene(87th base of SEQ ID NO:1) is G, -866GA SNP marker in which a -866th base from the transcription-starting point of the UCP-2 gene(63th base of SEQ ID NO:2) is G, +4787CT SNP marker in which a 4784th base from the transcription-starting point of the UCP-2 gene(53th base of SEQ ID NO:3) is C, and +791_45di SNP marker in which 45 bp bases from 7941th base from the transcription-starting point of the UCP-2 gene(45 bp bases from 253th base of SEQ ID NO:4) are added or deleted. A UCP2 haplotype marker for the prediction of susceptibility to coronary heart disease, in which -866th and 4787th bases from the transcription-starting point of the UCP-2 gene are G and C, respectively, is also provided. A method for the prediction of susceptibility to coronary heart disease and atherosclerosis comprises the steps of: (1) isolating the genomic DNA from a blood sample; (2) detecting the UCP-2 SNP site from the isolated genomic DNA; and (3) confirming the detected UCP-2 SNP site.
机译:提供了用于预测冠心病和动脉粥样硬化易感性的UCP-2(解偶联蛋白2)SNP(单核苷酸多态性)标记,以分析UCP-2 SNP与肥胖之间的相关性,尤其是血液胆固醇和动脉粥样硬化的指标。用于预测对冠心病和动脉粥样硬化的易感性的UCP-2 SNP标记是-1957G> A SNP标记,其中从UCP-2基因的转录起点起第-1957个碱基(SEQ ID NO:87个碱基) 1)是G,-866G> A SNP标记,其中从UCP-2基因的转录起始点起第-866个碱基(SEQ ID NO:2的第63个碱基)是G,+ 4787C> T SNP标记, UCP-2基因的转录起始点的第4784个碱基(SEQ ID NO:3的第53个碱基)是C,+ 791_45d> i SNP标记,其中从转录起始点的第7941个碱基起有45 bp的碱基添加或删除UCP-2基因(SEQ ID NO:4的第253个碱基的45bp碱基)。还提供了用于预测冠心病易感性的UCP2单倍型标记,其中从UCP-2基因的转录起始点开始的-866和4787碱基分别是G和C。预测冠心病和动脉粥样硬化易感性的方法包括以下步骤:(1)从血液样品中分离基因组DNA; (2)从分离的基因组DNA中检测UCP-2 SNP位点; (3)确认检测到的UCP-2 SNP位点。

著录项

  • 公开/公告号KR100874185B1

    专利类型

  • 公开/公告日2008-12-15

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR20060015652

  • 发明设计人 윤유식;김일철;차민호;임남희;

    申请日2006-02-17

  • 分类号C12Q1/68;

  • 国家 KR

  • 入库时间 2022-08-21 19:14:18

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号